Lindian Resources Limited Overview
Lindian Resources is a Perth-headquartered critical-minerals company transitioning from explorer to producer. Its cornerstone is the 100%-owned Kangankunde Rare Earths Project in Malawi's Balaka District, a carbonatite-hosted monazite deposit with a 261Mt Mineral Resource at 2.19% TREO and a 23.7Mt Probable Ore Reserve at 2.9% TREO supporting a ~45-year Stage 1 mine life. Stage 1 is under construction, fully funded, and targets first production of a premium ~55% TREO monazite concentrate in Q4 calendar 2026 at ~15,300tpa. Since March 2026 Lindian has pursued vertical integration: it now owns 100% of the SARECO hydrometallurgical plant in Stepnogorsk, Kazakhstan, to convert concentrate into mixed rare earth carbonate (MREC), and has a binding long-term offtake and oxide-separation partnership with France's Carester. Iluka Resources is a lender and concentrate offtaker. Legacy bauxite assets in Guinea and Tanzania are non-core. Key near-term risk is Malawian regulatory policy on domestic value-addition.
Company's own description
In its FY2025 Annual Report and subsequent ASX releases, Lindian describes itself as an Australian-based company with world-class rare earths and bauxite assets, with Kangankunde as the cornerstone of the portfolio and a stated ambition to become a globally significant critical minerals producer. It describes Kangankunde as producing a premium monazite concentrate at ~55% TREO grade with no deleterious elements, and since 2026 frames the strategy as an integrated "mine-to-MREC" and ultimately "mine-to-oxide" rare earths supply chain outside China. (Sources: FY2025 Annual Report, 26 Sep 2025; ASX announcements 2026.)
Independent characterisation
Lindian is a pre-revenue, single-asset-dominant rare earths developer on the cusp of first production. Its business model has three layers:
-
Upstream mining and beneficiation (Malawi). Owner-operator open-pit mining of carbonatite ore at Kangankunde, followed by a largely physical (gravity and magnetic) beneficiation circuit producing monazite concentrate. The deposit's low radionuclide and low acid-consumer profile is the core technical differentiator.
-
Midstream hydrometallurgy (Kazakhstan). Conversion of concentrate into MREC (and potentially mixed rare earth chloride) at the SARECO facility, using a conventional sulphuric acid bake / water leach / impurity removal / carbonate precipitation flowsheet validated by ANSTO.
-
Downstream separation (planned). A proposed ~8,000tpa REO solvent extraction (SX) oxide separation facility being studied with Carester and Tetra Tech Coffey, with study completion targeted by end-2026.
Revenue model. 100% product sales once operational (no service, subscription or licensing revenue). Planned revenue streams: (a) monazite concentrate sales to Iluka (6,000tpa over ~15 years) and other buyers; (b) MREC and heavy-rare-earth-enriched products sold to Carester (70% offtake) and other end-users; (c) potentially separated oxides in future. Current reported "revenue" is interest and other income only (A$2.45m in FY2026 per RTTNews summary of results).
Value-chain position. Mining → concentrate → MREC today (once commissioned), with an option on separation. This is unusual for an ASX junior: most peers sell concentrate only.
Customer types and end-markets. Rare earth refiners and separators (Iluka's Eneabba refinery in WA; Carester's Caremag in France), traders (historically Gerald Metals, now terminated), and indirectly permanent-magnet makers, automotive OEMs, wind-turbine, electronics and defence supply chains seeking non-Chinese NdPr, dysprosium and terbium. The company established an in-house sales and marketing function in Singapore in June 2026 and reports inbound interest from US, European and Japanese end users.
Strategy
Stated strategic themes
Across the FY2025 Annual Report and 2026 releases, management's themes are: (1) deliver Kangankunde Stage 1 safely, on time and fully funded; (2) become one of very few non-Chinese producers of both concentrate and MREC; (3) progress "mine-to-oxide" integration via Carester; (4) expand Kangankunde through Stage 2; (5) own the marketing function to capture payability and pricing control; (6) maintain constructive relations with the Malawian government on domestic beneficiation.
Initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Iluka strategic partnership | Aug 2025 | US$20m construction loan; 15-yr offtake of 90,000t (6,000tpa); ROFR on Stage 2 up to 375,000t contingent on Iluka funding 50% of expansion; no options/royalties; prepayable | Executed |
| Stage 1 FID | Aug 2025 | Approved alongside A$91.5m placement | Construction |
| Owner-operator mining | Sep 2025 | Self-mined rather than contractor model | Fleet delivered Dec 2025–Jan 2026; first blast late Jun 2026 |
| Stage 2 expansion DFS | 2025–2026 | Expanded 4.0Mtpa; ML area 2,500ha; DFS targeted Dec 2026 | In progress |
| SARECO MREC plant | Mar–Aug 2026 | 51% via IJV, then 100% (remaining 49% for US$20m cash) | First processing targeted Q4 2026 |
| A$100m placement | Apr 2026 | Funds Stage 1 completion buffer, Stage 2 and SARECO integration | Completed |
| Malawian bank facility | Apr 2026 | US$11.6m to support ramp-up | Secured |
| Marketing in-house (Singapore) | Jun 2026 | After Gerald termination | Operating |
| ANSTO downstream validation | Dec 2025 – Jul 2026 | 97% → 98% NdPr extraction; IAEA transport exemptions | Complete |
| Carester partnership | Sep 2026 | Offtake 10 yrs +2×5; ~8,000tpa REO SX facility DFS by year-end; management states SX facility to be funded from operating cash flows | Executed; study phase |
| Large-scale licence conversion | Aug–Sep 2026 | Moving from medium- to large-scale mining licence (implies higher royalty, possible state equity, community agreements) | In progress |
Guidance and targets
-
Front-end commissioning: October 2026 (late October per later updates).
-
Practical Completion: mid-November 2026.
-
First concentrate: Q4 calendar 2026.
-
SARECO first MREC processing: Q4 2026.
-
Stage 2 DFS: December 2026.
-
Carester SX facility study: by end-2026.
-
No revenue, EBITDA or cost guidance has been issued; Stage 1 economics per feasibility work (see §16).
Products & Services
Rare Earths
| Product / asset | Description and specifications | Target customer | Timing | Pricing model (as disclosed) |
|---|---|---|---|---|
| Kangankunde monazite concentrate | Premium concentrate at ~55% TREO, low thorium/uranium, limited acid-consuming minerals; produced mainly by gravity and magnetic separation. Stage 1 ~15,300tpa concentrate containing ~8,400tpa REO and ~1,640tpa NdPr | Iluka (Eneabba refinery), SARECO (internal feed, ~12,500tpa planned), others | First production targeted Q4 2026 | Iluka offtake priced off realised Eneabba NdPr oxide prices with payability structure offering downside protection and upside exposure incl. any government price support |
| Mixed Rare Earth Carbonate (MREC) | Produced at SARECO via sulphuric acid bake, water leach, impurity removal, carbonate precipitation. ANSTO: 98% NdPr extraction, 96% TREY extraction, ~96% overall NdPr recovery concentrate-to-MREC; certified exempt from radioactive transport/handling under IAEA SSR-6 | Carester (70% offtake), US/European/Japanese end users | First processing targeted Q4 2026 | Carester pricing linked to Carester's realised price and government floor prices; payabilities described as above typical market rates (company investor update) |
| Heavy-rare-earth-enriched products (MHREC / SEGH) | Mixed heavy rare earth carbonate and a samarium-europium-gadolinium-heavy (SEGH) fraction | Carester (ROFR over 70% of MHREC; purchase of 70% of SEGH) | Linked to separation facility development | As above |
| Separated oxides (planned) | Proposed ~8,000tpa REO SX facility in Kazakhstan; NdPr and heavy oxides | Magnet makers, OEMs | Study by end-2026; no construction decision | — |
| Kangankunde Stage 2 | Expansion to ~4.0Mtpa ore throughput; feasibility study previously identified potential for up to ~50,000tpa concentrate; Iluka ROFR over up to a further 375,000t | Iluka, others | Stage 2 DFS targeted Dec 2026 | — |
Bauxite
| Asset | Description | Status |
|---|---|---|
| Lelouma (Guinea) | ~900Mt JORC-compliant bauxite resource; 100% after acquiring remaining 25% (post-FY2025) | Non-core, held |
| Gaoual (Guinea) | Option with KB Bauxite Guinée SARLU (since Apr 2019); resource and digestion testwork reported 2021 | Non-core, held |
| Woula (Guinea) | Bauxite project | Non-core, held |
| Lushoto and Pare (Tanzania) | Bauxite projects | Non-core, held |
No pricing, launch dates or flagship "versions" apply to bauxite assets; no production.
Financial Narrative
Sources: TipRanks, Stockopedia and Kalkine (aggregating annual reports, IFRS, FY ending 30 June); FilingReader summary of FY2025 Annual Report; RTTNews summary of FY2026 results; Quartr summary of June 2026 quarterly. Aggregator labels such as "Dec 25" on TipRanks correspond to fiscal years ending 30 June (verified by matching to annual report figures).
Income statement: notes and sources
Notes: FY2022–FY2024 EPS derived (net income ÷ weighted shares). FY2025 net loss reported as A$9,292,227 in the Annual Report per FilingReader versus A$9.22m on aggregators (likely attributable vs total, or reclassification); both noted. FY2025 revenue line of A$0.278m per Kalkine is other/interest income; TipRanks reports operating revenue of nil. FY2026 figures per RTTNews: net loss A$31.84m, EPS -A$0.0213, revenue A$2.45m (+775% YoY). Margins and revenue CAGR are not meaningful for a pre-revenue company.
Balance sheet: notes and sources
Notes: FY2026 cash of ~A$108m is from the June 2026 quarterly (Appendix 5B) as summarised by Quartr, excluding ~A$17m of undrawn equipment finance and working capital facilities. A separate Quartr summary of the 6 Aug 2026 Diggers & Dealers presentation cites cash of A$56.97m; the discrepancy may reflect a later date (post-capex/SARECO payments) or a different measure and is unresolved.
Cash flow
The June 2026 quarter alone recorded net financing inflows of ~A$94.9m (Quartr), primarily the A$100m April 2026 placement net of costs. The A$91.5m August 2025 placement also fell in FY2026.
Ratios
Notes: ROE and ROA derived (FY2025 net loss ÷ year-end equity/assets). Current ratios from TipRanks (aggregator; mapping of columns to fiscal years inferred). ROIC, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are not meaningful for a pre-revenue, debt-free developer.
Commentary
Trend and inflections. The financial history divides cleanly into three phases. Through FY2022, Lindian was a micro-cap bauxite explorer spending ~A$1–2m a year. FY2023–FY2024 marks the Kangankunde pivot: investing outflows of ~A$22m and ~A$24m reflect acquisition tranches for RVRD and drilling/study spend, financed by ~A$30m and ~A$34m of equity. FY2025 was a "bridge" year: cash fell to A$3.49m at 30 June 2025, a precarious level, before the August 2025 Iluka partnership and A$91.5m placement transformed the balance sheet. FY2026 is the construction year: the net loss widened more than threefold to A$31.84m as corporate overheads scaled (new executives, General Counsel, Singapore office), share-based payments rose, and transaction costs (Gerald termination via 20m shares, SARECO due diligence) were expensed; interest income rose to ~A$2.45m on a much larger cash balance.
Drivers. Capitalised exploration/development drives the asset base; the income statement captures corporate costs, share-based payments and non-capitalisable items. The A$31.84m FY2026 loss composition (e.g., share-based payment expense, termination costs, foreign exchange) was not available in the sources reviewed.
Balance-sheet quality. Lindian has carried essentially no financial debt on balance sheet through FY2025 — rare for a developer — but has lined up ~US$31.6m of debt-like capacity (Iluka US$20m term loan; Malawian bank US$11.6m) plus equipment finance. Shareholder dilution has been heavy: shares outstanding rose ~40–45% in the year to late 2025 (Simply Wall St), with further issues in April and June 2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue incl. interest/other income (AUD Mn) | 0 | 0.009 | 0 | 0.278 | 2.45 |
Gross profit (AUD Mn) | -0.004 | 0.009 | -0.013 | -0.135 | — |
Operating expenses (AUD Mn) | 1.12 | 6.26 | 3.10 | 5.97 | — |
Operating income (AUD Mn) | -1.12 | -6.37 | -3.10 | -9.95 | — |
EBITDA (AUD Mn) | -1.15 | -7.67 | -4.87 | -9.44 | — |
Pre-tax income (AUD Mn) | -1.165 | -7.781 | -4.887 | -9.84 | — |
Net income (AUD Mn) | -1.16 | -7.73 | -4.78 | -9.22 | -31.84 |
Weighted avg shares (M) | 767.93 | 933.48 | 1,140 | 1,150 | — |
Basic EPS (AUD) | -0.0015 | -0.0083 | -0.0042 | -0.008 | -0.0213 |
Diluted EPS (AUD) | -0.0015 | -0.0083 | -0.0042 | -0.008 | -0.0213 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 7.49 | 64.30 | 79.13 | 76.55 | — |
Current assets (AUD Mn) | 2.23 | 7.80 | 13.44 | 3.91 | — |
Non-current assets (AUD Mn) | 5.26 | 56.50 | 65.69 | 72.64 | — |
Cash & equivalents (AUD Mn) | 2.18 | 7.62 | 13.25 | 3.49 | 108 |
Total debt (AUD Mn) | 0 | 0 | 0 | 0 | — |
Net debt (AUD Mn) | -2.18 | -7.62 | -13.25 | -3.49 | — |
Total liabilities (AUD Mn) | — | — | — | 18.19 | — |
Shareholders' equity (AUD Mn) | — | — | — | 58.36 | — |
Goodwill & intangibles (AUD Mn) | 0 | 0 | 0 | 0 | — |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -1.22 | -1.27 | -3.08 | -4.04 | -6.07 |
Capex / investing (AUD Mn) | -1.05 | -0.563 | -21.8 | -24.3 | -4.9 |
Free cash flow (AUD Mn) | -2.27 | -1.85 | -24.87 | -28.37 | -10.96 |
Financing cash flow (AUD Mn) | 2.16 | 3.51 | 30.3 | 34.0 | 1.2 |
Net change in cash (AUD Mn) | -0.113 | 1.68 | 5.44 | 5.64 | -9.76 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE (%) | — | — | — | -15.8 |
ROA (%) | — | — | — | -12.0 |
Current ratio (x) | 1.74 | 9.81 | 0.48 | 16.29 |
Debt/equity (x) | 0 | 0 | 0 | 0 |
Geographic Revenue
| Region (revenue, AUD Mn) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Africa – Malawi (AUD Mn) | 0 | 0 | 0 |
Africa – Guinea/Tanzania (AUD Mn) | 0 | 0 | 0 |
Central Asia – Kazakhstan (AUD Mn) | 0 | 0 | 0 |
Australia / corporate (AUD Mn) | 0 | 0 | 0 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Price at start of CY2026 | ~A$0.415 | InvestSMART |
CY2026 high | ~A$1.025 (21 Apr 2026) | InvestSMART |
CY2026 low | ~A$0.34 | InvestSMART |
Early Aug 2026 | ~A$0.76–0.78 | Kalkine; Simply Wall St |
Late Sep 2026 (latest observed) | ~A$0.445 | InvestSMART |
~1 year ago (mid-Oct 2025) | ~A$0.36–0.39 (Regal purchase prices) | Simply Wall St |
Placement price Aug 2025 | A$0.21 | Mining Technology |
Metric (AUD per share) | CY2022 | CY2023 |
Capital Markets
| Item | Status |
|---|---|
P/E, EV/EBITDA, EV/Sales | Not meaningful (pre-revenue, loss-making) |
Enterprise value | ~A$0.7bn (derived: ~A$0.8bn market cap less ~A$108m cash; excludes later spend) |
Dividends | None; no policy |
Credit ratings | Not rated |
Debt maturity | Iluka US$20m term loan (terms: prepayable without penalty); Malawian bank US$11.6m; equipment finance — maturities not disclosed |
Analyst Conclusions
Management guidance. Front-end commissioning late October 2026; Practical Completion mid-November 2026; first concentrate and first SARECO MREC processing in Q4 2026; Stage 2 DFS and Carester SX facility study by December 2026.
Consensus. No reliable published consensus for revenue or earnings was identified.
Bull case
-
Imminent producer status: Construction milestones are consistently hitting schedule; ~A$108m cash at 30 June 2026 removes near-term funding risk.
-
Integrated margin capture: owning SARECO and selling MREC under Carester's above-market payability terms should lift realised value well above concentrate-only peers.
-
Strategic scarcity: a low-radiation, long-life, non-Chinese NdPr and heavy rare earth source with Australian and French/Japanese-backed offtakers should command premium valuation.
Bear case
-
Sovereign risk: Malawi's push to require oxide processing before export (Sep 2026) could undermine the concentrate-to-Kazakhstan model.
-
Execution stack: first-time owner-operator mining, a refurbished Kazakh plant and intercontinental logistics must all work simultaneously.
-
Cost and dilution: the FY2026 loss tripled to A$31.84m and the share count has grown rapidly; Stage 2 and SX ambitions may require further capital despite "organic funding" claims.
Key catalysts and monitorables (next 12 months)
-
Resolution of the 28 Sep 2026 halt and Malawi law amendments.
-
Large-scale licence conversion terms (royalty rate, state equity).
-
Commissioning, first concentrate, nameplate ramp-up and recoveries.
-
First SARECO MREC and Carester shipments.
-
Stage 2 DFS (Dec 2026) and SX facility study.
-
September and December 2026 quarterlies; AGM 17 Nov 2026.
-
Index inclusion decisions; short-interest trajectory.
Analyst verdict
Lindian Resources has, in roughly fifteen months, converted Kangankunde from a stranded, under-funded asset into a fully financed construction project with credible downstream integration. The sequence — Iluka partnership and FID in August 2025, the A$100m placement in April 2026, the opportunistic purchase of a built MREC plant in Kazakhstan, ANSTO validation of the flowsheet, and the Carester offtake in September 2026 — reflects a management team that has moved quickly and capitalised on Western supply-chain policy. Technically, the asset's grade, clean mineralogy and radiological profile appear genuinely differentiated, and its Stage 1 capital intensity is among the lowest of any rare earths project globally.
The investment case, however, now hinges less on geology than on governance and geography. The most material risk is not Lindian's engineering but Malawi's evolving policy stance: three trading halts in under two months, a parliamentary call for suspension, and a proposal to mandate oxide processing within the country have all emerged just as production approaches. Lindian's prior success in obtaining regulatory clarification (October 2025, August 2026) is encouraging, yet each episode has shown the market will heavily discount the stock on any ambiguity. Layered on this is concentrated operational risk across three countries and an expanding corporate cost base.
On balance, Lindian represents a high-conviction, high-volatility development-to-production story. If the regulatory overhang clears and Kangankunde and SARECO commission broadly on schedule in Q4 2026, the company would be one of very few non-Chinese producers of both concentrate and MREC, and the current discount to its April 2026 peak would likely narrow. Conversely, a forced change to the export model would impair the economics of the integrated strategy. Investors should treat the next two quarterly reports and any Malawian legislative outcome as the decisive variables, and size positions accordingly.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Appointed | Background (as disclosed) |
|---|---|---|---|
Robert Martin | Executive Chairman | Chair from Dec 2024 (initially non-executive); executive role from 2025 | Prior chair roles at Critical Resources, Infini Resources, Pioneer Minerals/Lithium, Eminence/Equinox Minerals, Green360 Technologies; NED at Parkd, Volt Carbon Technologies, Battery Age Minerals. Holds ~2m LIN shares (~0.11%) |
Zekai "Zac" Komur | Executive Director (project delivery) | Director before 2025; executive director role from ~2H 2025 | Leads Kangankunde delivery and Stage 2 studies. Bought 500,000 shares Jun 2025 |
Teck Lim | Director | — | Co-presented Carester briefing Sep 2026; commented on CFO appointment |
Blake Steele | Non-Executive Director | Dec 2024 / early 2025 | — |
Derek Bideshi | Chief Financial Officer | Effective 6 Jul 2026 | Ex-GM Finance, Iluka; prior South32 and BHP; 18+ years in resources |
Rajesh Agrawal | GM Finance | Promoted Apr 2026 (joined Aug 2024) | 30+ years incl. Rio Tinto, Aditya Birla Group |
Anastasia Gotjamanos | General Counsel & Company Secretary | 25 May 2026 | Former Chief Legal Officer, Westgold Resources (2023–2026) |
Asimwe Kabunga | Chairman (NE then Executive) | Aug 2017 – 25 Nov 2024 | Tanzanian-born Australian entrepreneur; instrumental in Kangankunde acquisition; once the largest shareholder (~11%) |
Alistair Stephens | CEO | From Aug/Sep 2022 | Ex-MD Arafura Resources (Nolans Bore) |
Alwyn Vorster | CEO | 2024 | Led post-FS roadshow |
Trevor Matthews | Executive Director | — | Listed in historical profiles |
Ben Donovan (Argus Corporate Partners) | Company Secretary | Dec 2024 – 1 Jul 2026 | Outsourced cosec, replaced by in-house GC |
Major Shareholders
| Holder | Stake | Date / source |
|---|---|---|
Regal Funds Management / Regal Partners | 185.0m shares, 11.06% | Substantial holder notice 29 Jan 2026 (Market Index); position may have changed since |
L1 Capital | — | ShareCafe, Aug 2026 |
Wilson Asset Management (Active Fund) | — | ShareCafe, Aug 2026 |
Franklin Resources | — | Simply Wall St |
American Century Investment Management | — | Simply Wall St |
Bessemer Investment Management | — | Simply Wall St |
Prithvi Energy Nigeria Ltd | — | Simply Wall St insider data |
Gerald Metals SARL | 20m shares (90-day escrow) from Jun 2026 | ASX, 19 Jun 2026 |
UBS Group AG | Ceased substantial holding 29 May 2026 | FilingReader |
Robert Martin (insider) | ~2.0m shares (~0.11%) | MarketScreener |
Competitive Landscape
Key Competitors
| Company | Ticker | Asset / position | Relative positioning vs Lindian |
|---|---|---|---|
Lynas Rare Earths | ASX: LYC | Mt Weld (WA) + Kalgoorlie cracking + Malaysia separation + US projects; largest non-Chinese separated producer | Integrated incumbent; far larger scale |
MP Materials | NYSE: MP | Mountain Pass (US) mine, separation, magnets | US-integrated champion |
Iluka Resources | ASX: ILU | Eneabba refinery (WA), government-backed | Partner/customer; also feedstock competitor |
Arafura Rare Earths | ASX: ARU | Nolans (NT) integrated mine-to-oxide | Developer; higher capex |
Mkango Resources | TSXV/AIM: MKA | Songwe Hill (Malawi) | Same-jurisdiction developer |
Pensana | LSE: PRE | Longonjo (Angola) | African monazite peer |
Rainbow Rare Earths | LSE: RBW | Phalaborwa (South Africa) gypsum tailings | African peer, MREC-focused |
Hastings Technology Metals | ASX: HAS | Yangibana (WA) | ASX developer peer |
Meteoric Resources | ASX: MEI | Caldeira (Brazil) ionic clay | Heavy rare earths developer |
Australian Strategic Materials | ASX: ASM | Dubbo + Korean metals plant | Downstream-integrated peer |
China Northern Rare Earth / China Rare Earth Group | SSE | Dominant Chinese state-linked producers | Price-setters |
Peer Comparison FY2025
| Metric | Lindian | Lynas | MP Materials | Arafura |
|---|---|---|---|---|
Stage | Construction; first production Q4 2026 | Producer | Producer | Development |
Latest revenue | ~A$2.45m (interest, FY2026) | ~A$556m (FY2025, from memory of filings; verify) | ~US$204m (CY2024, from memory of filings; verify) | Nil (verify) |
Downstream capability | MREC (SARECO), SX planned | Full separation | Separation + magnets | Planned oxide |
Debt | ~Nil on balance sheet at FY2025 | — | — | — |
Recent Developments
--



